KATHLEEN RAZA: Open Payments
NPI 1497443915 · BOLINGBROOK, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$485 in 10 payments from 7 companies in 2025. Trend: 2023 $77 · 2024 $4,581 · 2025 $485
Food & beverage: $485
| Company | Payments | Amount |
|---|---|---|
| Mallinckrodt Hospital Products Inc. | 3 | $204 |
| GlaxoSmithKline, LLC. | 1 | $125 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $64 |
| Travere Therapeutics, Inc. | 1 | $31 |
| Aurinia Pharma U.S., Inc. | 1 | $23 |
| Novo Nordisk Inc | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
Products named: ACTHAR, BENLYSTA, Kerendia, LUPKYNIS, Ozempic, JYNARQUE.
Industry payments across IL — which companies pay providers there.
